Real-world outcomes following third or subsequent lines of therapy: A Danish population-based study on 189 patients with relapsed/refractory large B-cell lymphomas.
Al-Mashhadi AL, Jakobsen LH, Brown P, Gang AO, Thorsteinsson AL, Rasoul K, Haissman JM, Tøstesen MB, Christoffersen MN, Jelicic J, Jørgensen JB, Thomsen T, Dessau-Arp A, Andersen APH, Frederiksen M, Pedersen PT, Clausen MR, Jørgensen JM, Poulsen CB, El-Galaly TC, Larsen TS.
Al-Mashhadi AL, et al. Among authors: haissman jm.
Br J Haematol. 2024 Mar;204(3):839-848. doi: 10.1111/bjh.19201. Epub 2023 Nov 27.
Br J Haematol. 2024.
PMID: 38009548